The Food and Drug Administration on Saturday granted emergency approval to the COVID-19 drug used last month to treat President Donald Trump, clearing the antibody-based treatment from Regeneron for use in patients at risk of severe disease or hospitalization.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,